A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation

Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
12/2002
12/11/2002	EP1051421B1 Compounds containing boron for electron microscopy and for boron neutron-capture therapy
12/10/2002	US6493570 Administering a halogenated xanthene to a patient prior to imaging, a portion of said halogenated xanthene being retained in said diseased tissue; and imaging said patient using a detected signal from said halogenated xanthene
12/10/2002	US6492420 Such as methyl ester; more effective than free form at slowing tumor growth
12/06/2002	WO2001096344A1 Novel expanded porphyrins and process for the synthesis thereof
12/05/2002	WO2002096896A1 Biologically active methylene blue derivatives
12/05/2002	WO2002096516A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
12/05/2002	WO2002096471A2 Viral inactivation process using antioxidant
12/05/2002	WO2002096437A1 Neutron capture therapy
12/05/2002	WO2002096366A2 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
12/05/2002	WO2002096365A2 Method for improving treatment selectivity and efficacy using intravascular photodynamic therapy
12/05/2002	WO2002062397A3 Chelates of metals which can be activated by neutrons and their use for the measurement of labeled specimens
12/05/2002	US20020183808 Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and surfactant
12/05/2002	US20020183386 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
12/05/2002	US20020183302 Providing, at a frequency of at least about every 45 days during at least a period of three months following an initial photodynamic therapy (PDT), additional PDT treatments to subject after evaluations for neovascular leakage
12/05/2002	US20020183301 Method for improving treatment selectivity and efficacy using intravascular photodynamic therapy
12/05/2002	US20020183245 For therapy of Porphyromonas (Bacteroides) gingivalis; periodontal disorder
12/05/2002	CA2448562A1 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
12/05/2002	CA2447657A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
12/04/2002	EP1262179A1 Photodynamic therapy for selectively closing neovasa in eyeground tissue
12/03/2002	US6488032 Method of providing cosmetic/medical therapy
11/2002
11/28/2002	WO2002094271A1 Targeted delivery of bioaffecting compounds for the treatment of cancer
11/28/2002	WO2002094260A1 New use of indocyanine green as a photosensitive agent
11/28/2002	US20020177704 Nitroimidazole substituted porphyrin complex
11/28/2002	US20020177186 Controlling protein synthesis in situ; obtain amino acid sequence, associate acoustic frequency with amino acids, determine frequencies for amino acid sequence, determine tone quality, use tone to control biosynthesis of protein
11/28/2002	DE10123505A1 New immunoconjugate comprising egg yolk immunoglobulin Y, useful for treating e.g. inflammation or infection, is derived from specific pathogen-free hens
11/27/2002	EP1259264A2 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation
11/27/2002	EP1259237A1 Treatment or prevention of prostate cancer with a cox-2 selective inhibiting drug
11/26/2002	US6486179 Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
11/26/2002	US6486170 Phospholipase A2 inhibitors as mediators of gene expression
11/26/2002	US6485704 Azo compound for type I pototherapy
11/25/2002	CA2348853A1 Novel carborane analogs of tamoxifen
11/21/2002	WO2002092136A2 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy
11/21/2002	WO2002092103A1 Chemoprotection using amifostine and related compounds
11/21/2002	WO2002024226A8 Photosensitisers
11/21/2002	US20020173833 Apparatus and method for high energy photodynamic therapy of acne vulgaris, seborrhea and other skin disorders
11/21/2002	US20020173832 Reduced fluence rate PDT
11/21/2002	US20020173523 Immunosuppression by photochemotherapy
11/21/2002	US20020173451 Using mixture of prostate specific antigen and radiation therapy
11/21/2002	CA2447287A1 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy
11/21/2002	CA2446736A1 Chemoprotection using amifostine and related compounds
11/20/2002	EP1257268A2 Diagnostic and therapeutic compositions and methods for affecting tumor growth using oxygen mimetic agents
11/20/2002	EP1073472B1 Solution containing an ester of ala for diagnosing or treating tissue pathologies
11/20/2002	EP0711127B1 Methods of preparing gas-filled liposomes
11/20/2002	CN1380105A Biological preparation medicine modulated by micro-alternating biological electric field for curing diabetes and its production method
11/20/2002	CN1380104A Biological preparation medicine modulated by micro-alternating biological electric field for curing cancer and its production method
11/20/2002	CN1380103A Biological preparation module by micro-alternating biological electric field for curing benign tumor and its production method
11/20/2002	CN1380102A Biological preparation medicine modulated by micro-alternating biological electric field for curing AIDS and its production method
11/20/2002	CN1380101A Biological immunomodulator for preventing and curing mad cattle disease and its production method
11/20/2002	CN1380100A Biological immunomodulator for animal for curing and preventing foot and mouth disease and its production method
11/20/2002	CN1380099A Human body immunomodulator modulated by micro-alternating biological electric field and its preparation method
11/19/2002	US6482436 Magnetically responsive composition
11/14/2002	WO2002090390A1 Hyaluronic acid containing bioconjugates : targeted delivery of anti-cancer drugs to cancer cells
11/14/2002	WO2002090361A1 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
11/14/2002	WO2002089858A1 Azo compounds for type i phototherapy
11/14/2002	WO2002089750A2 Apparatus and method of photodynamic eradication of organisms utilizing pyrrolnitrin
11/14/2002	US20020169394 Integrated tissue poration, fluid harvesting and analysis device, and method therefor
11/14/2002	US20020169235 Which absorbs electromagnetic radiation, and uses the energy to trigger drug delivery; for multiples injections; diabetes
11/14/2002	US20020169107 Azide bioconjugates for phototherapy of tumors and other lesions
11/14/2002	US20020168338 Compositions and methods for delivery of agents for neuronal regeneration and survival
11/14/2002	CA2445985A1 Hyaluronic acid containing bioconjugates: targeted delivery of anti-cancer drugs to cancer cells
11/13/2002	EP1255725A2 5-aminolevulinic acid formulation dissolved/dispersed in non-aqueous solvents
11/13/2002	EP1255533A2 Magnetoliposome composition for targeted treatment of biological tissue
11/13/2002	EP1090006A4 Alkyl ether analogs of chlorins having an n-substituted imide ring
11/12/2002	US6479053 Laser inactivation of inhibitory molecules in central nervous system myelin
11/12/2002	US6479034 Method of preparing gas and gaseous precursor-filled microspheres
11/12/2002	CA2101227C Chlorophyll and bacteriochlorophyll derivatives and pharmaceutical compositions containing them
11/07/2002	WO2002088336A2 Genetically modified yt cell line and use thereof
11/07/2002	WO2002087700A1 Method, kit and device for the treatment of cosmetic skin conditions
11/07/2002	WO2002069892A3 METHOD FOR PROTECTING CELLS AND TISSUES FROM IONIZING RADIATION TOXICITY WITH α, β UNSATURATED ARYL SULFONES
11/07/2002	WO2001026676A9 Methods of treating or preventing cell, tissue, and organ damage using human myeloid progenitor inhibitory factor-1 (mpif-1)
11/07/2002	WO2001015745A9 Method and formula for tumor remission and suppression of cancer
11/07/2002	US20020165594 Apparatus and method of photodynamic eradication of organisms utilizing pyrrolnitrin
11/07/2002	US20020165210 Tumor chemopotentiation using isocoumarin derivatives
11/07/2002	US20020165179 Multifunctional nanodevice platform
11/07/2002	US20020164287 Azo compounds for type i phototherapy
11/07/2002	CA2445593A1 Genetically modified yt cell line and use thereof
11/06/2002	EP1253943A2 Photodynamic therapy for treating conditions of the eye
11/06/2002	EP1253911A1 Method for loading a red blood cell with an agent
11/06/2002	EP0781150B1 Enhanced transdermal transport using ultrasound
11/06/2002	EP0623134B1 Metal complexes of water soluble texaphyrins
11/06/2002	CN1093766C Use of thexpahyrin in preparation of medicament for use with a chemotherapeutic agent in cancer chemosensitization
11/05/2002	US6475508 Methods and pharmaceutical compositions for the closure of retinal breaks
10/2002
10/31/2002	WO2002085459A2 Antiangiogenic combination therapy for the treatment of cancer
10/31/2002	WO2002076935A8 Novel a-lipoic acid derivative and use thereof
10/31/2002	WO2001087348A3 Multifunctional nanodevice platform
10/31/2002	WO2001052746A9 Versatile hydrophilic dyes
10/31/2002	US20020161035 Medicaments for chemotherapeutic treatment of disease
10/31/2002	US20020160984 For example, 2,3-dihydro-1H-benz(de)isoquinolin-1-one; treating diabetes, cancer, radiosensitizing tumor cells, cardiovascular disorders, septic shock, inflammatory bowel disease, senescent cells
10/31/2002	US20020160969 Nucleosides and oligonucleotides containing boron clusters
10/31/2002	US20020160061 Use of legume products for the treatment of external aggressions
10/31/2002	US20020159952 Novel acoustically active drug delivery systems
10/31/2002	US20020159951 Administering to the patient a contrast agent comprising, in an aqueous carrier, targeted vesicles formulated from a lipid or polymer, a prfluorocarbon gas, a targeting ligand, scanning the patient using ultrasound to obtain an image
10/31/2002	DE10121113A1 Genmodifizierte YT Zelllinie und ihre Verwendung Genetically Modified YT cell line and their use
10/31/2002	CA2444219A1 Antiangiogenic combination therapy for the treatment of cancer
10/30/2002	EP1253150A1 Polymeric micellar structure
10/30/2002	EP1253139A2 Multioligoanilinated fullerenes
10/30/2002	EP1252885A2 Methods of preparing gas and gaseous precursor-filled microspheres
10/30/2002	EP1251828A1 Local drug delivery using photosensitizer-mediated and electromagnetic radiation-enhanced vascular permeability
10/29/2002	US6471988 Protecting a skin area against light when detecting and/or treating skin disorders, especially cancer, in connection with which a photoreactive substance in the skin area; opaque foil
10/29/2002	US6471968 Multifunctional nanodevice platform

1 ... 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 ... 95